Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer

NCT01592422 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

BIOLOGICAL: Autologous cytokine-induced killer cell
OTHER: Best Supportive Care

Sponsor

People's Hospital of Guangxi Zhuang Autonomous Region